FDA approves Spravato, a fast-acting antidepressant nasal spray - TMC News
Mayo

FDA approves Spravato, a fast-acting antidepressant nasal spray - TMC News

2743 × 1718 px September 26, 2025 Zeus

FDA approves Spravato, a fast-acting antidepressant nasal spray - TMC News is a high-quality image in the Mayo collection, available at 2743 × 1718 pixels resolution — ideal for both digital and print use.

Understand common Spravato side effects, including dissociation and nausea. Learn safety tips and management strategies for this esketamine treatment.

Image Details

TitleFDA approves Spravato, a fast-acting antidepressant nasal spray - TMC News
Dimensions2743 × 1718 px
CategoryMayo
PublishedSeptember 26, 2025
AuthorZeus
Downloads2,439
Views266

Frequently Asked Questions

This image has a resolution of 2743 × 1718 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Mayo collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 2743 × 1718 px.
Yes! Scroll down to the More Images section below to explore related Mayo images. You can also visit the full article for more context and a complete image gallery.

Read full article: Spravato Side Effects